Skip to main content

Advertisement

Table 2 Characteristics of HS and PD patients enrolled in study 2. Data are means ± SD unless otherwise indicated

From: Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

  HS PD-dn PD-dt P
HS vs PD-dn HS vs PD-dt PD-dn vs PD-dt
n 33 30 36
Gender (M/F) 19/14 16/14 20/16 0.803 0.799 1.000
Age (years) 65.1 ± 11.4 68.2 ± 9.1 70.0 ± 8.1 0.241 0.133 0.698
UPDRS part III (score) 14.2 ± 7.0 17.3 ± 8.4 0.076
 1–10 (n) 14 7 0.051
 11–20 (n) 9 19
  > 20 (n) 7 10
H&Y scale (stage) 1.4 ± 0.5 1.9 ± 0.8 0.002
 1.0 (n) 17 10 0.014
 1.5–2.0 (n) 12 17
  > 2.5 (n) 1 9
LED (mg/day) 522.3 ± 356.5
Drugs
l-DOPA (n) 31a
DA agonists (n) 17b
 Pramipexole (n) 8
 Ropinirole (n) 6
 Rotigotine (n) 3
Rasagiline (n) 19
  1. a15 taking l-DOPA alone, and 16 taking l-DOPA + DA agents
  2. b4 taking DA agonists alone (2) or with rasagiline (2), and 13 taking DA agonists + l-DOPA, without (10) or with rasagiline (3)